SCOTOMAS IN THE VISUAL FIELD AS THE FIRST SIGN OF INTRACRANIAL EXPANSION. CASE REPORT

The most common cause of visual field loss in ophthalmology is glaucoma. Other causes of visual field damage include local damage to the eye itself in intrabulbar or retrobulbar neuritis or injuries. However, they can also be caused by general diseases, e.g. in endocrine orbitopathy, toxic and nutritional neuropathy, or in diseases that are localized intracranially. Each of these findings in itself suggests the nature of the lesion, its intracranial location, lateral occurrence, as well as in which part of the visual pathway the lesion is located. The use of perimeter has therefore become the primary examination method, which is available, is not demanding and will quickly allow a diagnosis to be made. When found on a perimetric examination, it is necessary to indicate targeted imaging examinations, such as computed tomography or magnetic resonance imaging. The article describes a patient who was primarily examined at the Department of Ophthalmology, Faculty of Medicine, Comenius University and the University hospital of Bratislava. The patient reported visual field outages, and after subsequent computed tomography, she was interdisciplinary managed and surgery was done on at the Neurosurgical Department. After the operation, there was a significant improvement without a pathological finding on the perimeter.

Bronchial inflammation in seasonal allergic rhinitis with or without asthma in relation to natural exposure to pollen allergens

BACKGROUND

Nasal inflammation in allergic rhinitis enhances bronchial Th2 driven inflammation and development of asthma. We assessed bronchial inflammation induced by natural allergen exposure during pollen season in patients with pollinosis with or without asthma to show the intensity of inflammation in asthma and rhinitis and possible persistence of inflammation in periods without allergen exposure.

METHODS

Sputum was induced in 52 patients with seasonal allergic rhinitis without asthma, 38 patients with seasonal allergic rhinitis and seasonal asthma and 23 healthy volunteers. Sampling was performed 6-8 weeks before the expected beginning of symptoms, during symptomatic period and 6-8 weeks after the end of symptoms. Sputum ECP was measured by means of chemi-luminiscent immunometric assay and sputum cell counts were assessed by classical staining and immunocytochemistry.

RESULTS

Sputum eosinophils were on the whole higher in both asthma and rhinitis compared to controls (p<0.001, p=0.003). The rise of eosinophils during pollen season compared with values out of pollen season was significant in asthma (classical staining) (p=0.014) and slightly apparent in rhinitis (immunocytochemistry) (p=0.073). The seasonal rise of sputum ECP was observed only in rhinitis (p=0.006).

CONCLUSIONS

Inflammation of the lower airway in patients with allergic rhinitis with and without asthma has been confirmed by means of both sputum eosinophil count and sputum ECP level. Persistent inflammation of lower airway in periods without allergen exposure was proven in seasonal asthma. This may have implications for the therapy of seasonal allergic rhinitis with and without asthma in terms of promoting long-term anti-inflammatory treatment.